Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast CancerBusiness Wire • 11/14/20
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQBusiness Wire • 11/04/20
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor MeetingBusiness Wire • 10/29/20
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020Business Wire • 10/19/20
Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 AwardBusiness Wire • 10/15/20
Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer CasesBusiness Wire • 10/08/20
3 Picks to Ride the Coronavirus-Led Strength in Lab Plastic SpaceZacks Investment Research • 09/29/20
Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-SeqBusiness Wire • 09/01/20
Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription ModelBusiness Wire • 08/27/20
Agilent Technologies Inc. (A) CEO Mike McMullen on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/19/20
Agilent Earnings, Sales Beat Wall Street Expectations; Agilent Stock Edges UpInvestors Business Daily • 08/18/20